Mutations in the ADAMTS13 gene are one of the key pathological mechanisms of congenital TTP, whereas, heterogeneous and polyclonal autoimmune response against ADAMTS13 is the critical mechanism for acquired TTP (8). This evidence concerns the gene ADAMTS13 and thrombotic thrombocytopenic purpura.